Author

Ulrich Freudensprung

PERFUSE: A FRENCH NON-INTERVENTIONAL COHORT STUDY OF INFLIXIMAB-NAÏVE AND TRANSITIONED PATIENTS RECEIVING INFLIXIMAB BIOSIMILAR SB2; ANALYSIS OF 24-MONTH DATA
PERFUSE: A FRENCH NON-INTERVENTIONAL COHORT STUDY OF INFLIXIMAB-NAÏVE AND TRANSITIONED PATIENTS RECEIVING INFLIXIMAB BIOSIMILAR SB2; ANALYSIS OF 24-MONTH DATA

Ulrich Freudensprung  et al.

PERFUSE: A FRENCH PROSPECTIVE/RETROSPECTIVE NON-INTERVENTIONAL COHORT STUDY OF INFLIXIMAB-NAïVE AND TRANSITIONED PATIENTS RECEIVING INFLIXIMAB BIOSIMILAR SB2; INTERIM ANALYSIS
PERFUSE: A FRENCH PROSPECTIVE/RETROSPECTIVE NON-INTERVENTIONAL COHORT STUDY OF INFLIXIMAB-NAïVE AND TRANSITIONED PATIENTS RECEIVING INFLIXIMAB BIOSIMILAR SB2; INTERIM ANALYSIS

Ulrich Freudensprung  et al.

PERFUSE: A FRENCH NON-INTERVENTIONAL COHORT STUDY OF ADALIMUMAB-NAÏVE AND TRANSITIONED PATIENTS RECEIVING ADALIMUMAB BIOSIMILAR SB5; BASELINE RESULTS
PERFUSE: A FRENCH NON-INTERVENTIONAL COHORT STUDY OF ADALIMUMAB-NAÏVE AND TRANSITIONED PATIENTS RECEIVING ADALIMUMAB BIOSIMILAR SB5; BASELINE RESULTS

Ulrich Freudensprung  et al.

Item 1 - 3 / 3
1